Filing Details

Accession Number:
0001593968-21-002313
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-29 20:19:25
Reporting Period:
2021-03-13
Accepted Time:
2021-10-29 20:19:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
738214 Aemetis Inc AMTX Industrial Organic Chemicals (2860) 261407544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1460201 Sanjeev Gupta 20400 Stevens Crek Blvd, Suite 700
Cupertino CA 95014
Executive Vice President, Md No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-13 8,503 $20.83 141,497 No 4 F Direct
Common Stock Disposition 2021-03-16 47,293 $19.54 94,204 No 4 S Direct
Common Stock Disposition 2021-03-17 91,270 $18.92 2,934 No 4 S Direct
Common Stock Disposition 2021-04-19 1,192 $18.99 39,442 No 4 F Direct
Common Stock Disposition 2021-04-19 36,449 $20.08 2,993 No 4 S Direct
Common Stock Disposition 2021-06-16 13,835 $13.77 64,158 No 4 F Direct
Common Stock Disposition 2021-06-16 53,269 $14.21 10,889 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 F Direct
No 4 S Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.
  2. These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.
  3. These shares were sold pursuant to a Rule 10b5-1 plan.
  4. As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 0 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the June 16, 2021 option exercise in which the Reporting Person sold all but 10,889 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 143 shares of the Issuers common stock.